Fast tracked shots contain toxic ingredients mercury and squalene
Monday, Sept 28, 2009
Children as young as six months are being used in tests beginning today on two “fast tracked” and unlicensed flu vaccines containing ingredients that are known to cause neurological disorders and nerve diseases.
Over the next two weeks 1,000 children aged six months to 12 years are being recruited in Oxford, Bristol, Southampton, Exeter and London, to determine which vaccine “has fewer side-effects”, reports the BBC.
“The idea is that everyone will be given this medicine to stop them from catching swine flu.” the BBC states on it’s children’s news website Newsround.
The trials mirror those carried out on children in the U.S. in the Summer.
One of the vaccines is GlaxoSmithKilne’s Pandemrix, which is actually a pre-pandemic influenza vaccine for the H5N1 virus, or Bird flu. The other shot is Baxter International’s H1N1 vaccine.
Neither of the vaccines have been licensed, while the Baxter vaccine hasn’t even been approved for use by the European Medicines Agency.
In addition, the EMEA states on its pandemic website that there is “no clinical experience in the elderly, in children or in adolescents” with Pandemrix.
“There is currently very limited clinical experience with an investigational formulation of Pandemrix (H1N1) containing a higher amount of antigen (see section 5.1) in healthy adults aged 18-60 years and no clinical experience in the elderly, in children or in adolescents.” the site notes.
Authorisation was fast tracked for the vaccine based on research using “mock up” bird flu vaccines dating from 2007 and 2008, according to the EMEA.
The vaccine has been rushed through safety procedures while the government has provided pharmaceutical companies with blanket immunity from lawsuits arriving out of the vaccine causing deaths and injuries.
The UK Government has intimate links with the makers of the Pandemrix vaccine, given that one its top advisors on swine flu also happens to be a sitting board member of GlaxoSmithKline.
The pharmaceutical company is currently facing fierce backlash regarding it’s cervical cancer vaccine Cervarix, after a 14-year-old British girl died soon after getting the shot at school earlier this week.
We have previously reported on the controversial appointment of Baxter to manufacture H1N1 vaccine after the company was involved in shipping out vaccines containing live bird flu virus last year.
In related news, the package insert of the Novartis H1N1 vaccine (based on an earlier vaccine product known as Fluvirin) lists known side effects as guillain-barre syndrome, vasculitis, anaphylactic shock and even death.
This article was posted: Tuesday, September 29, 2009 at 9:53 am